Literature DB >> 8636727

Limitations in upper-body strength associated with breast cancer: a comparison of black and white women.

W A Satariano1, D R Ragland, G N DeLorenze.   

Abstract

We examined differences in reported upper-body limitations between black and white breast cancer cases and controls aged 40 to 84 years at 3 and 12 months after diagnosis in the Detroit metropolitan area (n = 954 cases and 1000 controls at 3 months; n = 879 cases and 909 controls at 12 months). At 3 months black cases were more likely than white cases to report limitations in upper-body strength (30.4 versus 19.8%). No difference was found between black and white controls (8.0 versus 9.4%). At 12 months, the proportion of white patients with upper-body limitation returned to the same level as white controls. Black patients with limitations, however, did not return to the same level as black controls. Stage of disease was strongly associated with upper-body limitations, especially for black women. Race and stage differences in upper-body limitation could not be explained by differences in breast cancer treatment, financial adequacy, education, marital status, or comorbidity. Recommendations are made for more comprehensive studies of rehabilitation.

Entities:  

Mesh:

Year:  1996        PMID: 8636727     DOI: 10.1016/0895-4356(95)00565-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Return to work in low-income Latina and non-Latina white breast cancer survivors: a 3-year longitudinal study.

Authors:  Victoria S Blinder; Sujata Patil; Amardeep Thind; Allison Diamant; Clifford A Hudis; Ethan Basch; Rose C Maly
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

2.  Unemployment and the likelihood of detecting early-stage breast cancer.

Authors:  R A Catalano; W A Satariano
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

3.  How do recovery advice and behavioural characteristics influence upper-body function and quality of life among women 6 months after breast cancer diagnosis?

Authors:  Tracey Round; Sandra C Hayes; Beth Newman
Journal:  Support Care Cancer       Date:  2005-07-13       Impact factor: 3.603

4.  Assessing task "burden" of daily activities requiring upper body function among women following breast cancer treatment.

Authors:  Sandi C Hayes; Diana Battistutta; Anthony W Parker; Cherrell Hirst; Beth Newman
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

5.  Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women.

Authors:  V S Blinder; M M Murphy; L T Vahdat; H T Gold; I de Melo-Martin; M K Hayes; R J Scheff; E Chuang; A Moore; M Mazumdar
Journal:  J Community Health       Date:  2012-08

6.  Long-term prognostic role of functional limitations among women with breast cancer.

Authors:  Dejana Braithwaite; William A Satariano; Barbara Sternfeld; Robert A Hiatt; Patricia A Ganz; Karla Kerlikowske; Dan H Moore; Martha L Slattery; Martin Tammemagi; Adrienne Castillo; Michelle Melisko; Laura Esserman; Erin K Weltzien; Bette J Caan
Journal:  J Natl Cancer Inst       Date:  2010-09-22       Impact factor: 13.506

7.  Shoulder impairment before breast cancer surgery.

Authors:  Ann Marie Flores; Kathleen Dwyer
Journal:  J Womens Health Phys Therap       Date:  2014-09

8.  Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life.

Authors:  Sandra C Hayes; Sheree Rye; Diana Battistutta; Tracey DiSipio; Beth Newman
Journal:  Health Qual Life Outcomes       Date:  2010-08-31       Impact factor: 3.186

9.  Factors influencing changes in employment among women with newly diagnosed breast cancer.

Authors:  Michael J Hassett; A James O'Malley; Nancy L Keating
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

10.  Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.

Authors:  Dejana Braithwaite; Dan H Moore; William A Satariano; Marilyn L Kwan; Robert A Hiatt; Candyce Kroenke; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.